Last reviewed · How we verify
NCT07506161
Radiofrequency Ablation Treatment of Low-Risk Papillary Thyroid Carcinomas
trial testing Radiofrequency ablation alone in Papillary Thyroid Microcarcinoma in 27 participants. Completed in 31 December 2025.
31 December 2025
Quick facts
| Lead sponsor | Premier G Med Cardio Kft |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 27 |
| Start date | 9 September 2021 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across Hungary |
Drugs / interventions tested
- Radiofrequency ablation alone — full drug profile →
Conditions studied
- Papillary Thyroid Microcarcinoma — all drugs for Papillary Thyroid Microcarcinoma →
Sponsor
Premier G Med Cardio Kft
Who can join
18 and older, any sex, with Papillary Thyroid Microcarcinoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Researchers in this study aim to prove the safety and efficacy of radiofrequency ablation in the treatment of a carefully selected low-risk papillary thyroid microcarcinoma patient group.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07506161
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Radiofrequency ablation alone
Trials testing the same drug.
- NCT07206121 — Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery · NA · recruiting
- NCT07416448 — Neuroma-Associated Pain Management After Combat-Related Trauma in Ukraine · NA · recruiting
- NCT07380789 — Comprehensive Multicenter Study on the Management of Acute Pain Following Thoracic Combat-Related Trauma in Ukraine · NA · recruiting
- NCT07126535 — Impact of RFA on Esophageal Distensibility and Mucosal Impedance · recruiting
- NCT06796348 — Radiofrequency Ablation Versus Hemithyroidectomy of Small Thyroid Cancers · NA · not yet recruiting
Other recruiting trials for Papillary Thyroid Microcarcinoma
Currently open trials in the same condition.
- NCT07054229 — Efficacy and Prognosis of Microwave Ablation Treatment for Papillary Thyroid Microcarcinoma Assessed by Contrast-Enhance · recruiting
- NCT06333587 — Minimally Invasive Treatments of the Thyroid · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07506161 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Premier G Med Cardio Kft
- Last refreshed: 1 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07506161.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing